CompletedNot Applicable

Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes

United States12 participantsStarted 2020-06-25

Plain-language summary

To determine if early apical release holmium enucleation of the prostate (EAR HoLEP), as a surgical treatment for benign prostatic hyperplasia, reduces post-operative urinary incontinence compared to classic HoLEP.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients must be 18 years of age or older * Patients must present to clinic with a diagnosis of benign prostatic hyperplasia * Patients must be scheduled to undergo a holmium laser enucleation of the prostate Exclusion Criteria: * Patients with previous surgical management of BPH * Patients with prostate biopsy revealing high risk prostate cancer * Patients with a concomitant neurogenic bladder diagnosis (SCI, Parkinson, MS, cerebral palsy)

What they're measuring

Post-operative Urinary Incontinence

Timeframe: Twelve Months Post-operative

Trial details

NCT IDNCT04566588

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05-11

View on ClinicalTrials.gov More Benign Prostatic Hyperplasia trials